Original Article: Evaluation of the efficacy of Ischemia Reversal Program (IRP) in patients suffering from Ischemic Heart Disease (IHD) with known history of Hypertension: A Retrospective Study
Journal: Journal of Ayurveda Medical Sciences
Clinical Study: J Ayu Med Sci 2018; Apr-Jun 3(2): 377-83.
Click to Download Full Research Paper
Journal Published Link: https://www.jayumedsci.com/article/2018/3/2/105530jams2018317
Abstract
Introduction: Cardiovascular mortality has risen in the last few years, and Ischemic Heart Disease (IHD) is one of the most common causes. The Ischemia Reversal Program (IRP) kit uses a combination of Snehana (Centripetal oleation), Swedana (Thermal vasodilation) and Basti (Per rectal drug administration) for providing relief to IHD patients. This study was conducted to evaluate the efficacy of IRP in IHD patients. Methods: This retrospective study included data of patients having positive inducible ischemia by stress test with a known history of hypertension (HTN) and had visited the Madhavbaug clinics. A minimum of 7 IRP settings were needed for inclusion. Duke Treadmill score, VO2 max, systolic plus diastolic blood pressure (SBP, DBP) and details of conventional medications were noted on day 1 and day 90, followed by a comparison between these values. Results: Nineteen patients with a mean age of 59.26 ± 8.03 years were enrolled, with 78.9% being male. On day 90, none of the patients were at high risk by Duke Treadmill Score, compared to 47.4% being at high risk on day 1 (p<0.01). Mean VO2 max significantly increased on day 90 of IRP therapy (p<0.01) while mean SBP and DBP decreased, though not significantly (p>0.05). The number of subjects on allopathic medicines decreased by day 90 compared to day 1. Conclusion: IRP treatment is associated with significant improvement in the Duke Treadmill score and VO2 max, thereby leading to betterment of prognosis in IHD patients. The dependency on conventional medicines was also decreased by the IRP.
Keywords: Coronary artery disease, Duke’s Treadmill test, Ischemia Reversal Program, Myocardial ischemia
